4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Germ Cell Tumor: new trials by email Literature Review of Germ Cell Tumor trials Research Report on Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors Brentuximab Vedotin, Bevacizumab - Germ Cell Tumor | Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 1 | 2017-03-29 | 2020-12-10 |
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors Durvalumab, Tremelimumab - Germ Cell Tumor | Phase 2 | Terminated | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 36 | 2017-02-01 | 2021-05-14 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Genistein, Placebo - Lymphoma, Childhood Lymphoma | Phase 2 | Terminated | University of Virginia | 4 | 2016-08-01 | 2024-05-06 |
| Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors Cisplatin plus Epirubicin - Germ Cell Tumor | Phase 2 | Terminated | Indiana University | 37 | 2000-10-01 | 2014-06-03 |
Neoplasms, Germ Cell and Embryonal (4) · Brain Neoplasms (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Medulloblastoma (1) · Neoplasms (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1) · Testicular Neoplasms (1) · Wilms Tumor (1)
Neoplasms by Histologic Type (4) · Neoplasms (3) · Male Urogenital Diseases (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1)
Bevacizumab (1) · Brentuximab Vedotin (1) · Cisplatin (1) · Epirubicin (1) · Genistein (1) · durvalumab (1) · tremelimumab (1)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Indiana University (1) · Masonic Cancer Center, University of Minnesota (1) · University of Virginia (1)
United States (3) · Italy (1)
Lawrence Einhorn, M.D. (1) · Shilpa Gupta (1) · William C. Petersen, Jr., M.D. (1)